3-(4-甲氧基苯氨基)-丙酸 | 178425-91-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 3-(4-甲氧基苯氨基)-丙酸
• 中文别名: 3-(4-甲氧基苯基)氨基丙酸
• 英文名称: N-(4-methoxy-phenyl)-β-alanine
• 英文别名: N-(4-Methoxy-phenyl)-β-alanin；3-(4-methoxyanilino)propionic acid；3-<4-Methoxy-anilino>-propionsaeure；β-(3-Methoxyanilino)-propionsaeure；3-(4-Methoxy-phenylamino)-propionic acid；3-(4-methoxyanilino)propanoic acid
• CAS: 178425-91-7
• 化学式: C₁₀H₁₃NO₃
• mdl: MFCD03988000
• 分子量: 195.218
• InChiKey: HLBRZWKCTRYLRH-UHFFFAOYSA-N

物化性质

• 熔点：
  87-88 °C
• 沸点：
  402.7±30.0 °C(Predicted)
• 密度：
  1.216±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  58.6
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 海关编码：
  2922509090

反应信息

• 作为反应物：
  描述：

  3-(4-甲氧基苯氨基)-丙酸 在 三溴化硼 、 溶剂黄146 作用下， 以 二氯甲烷 为溶剂， 反应 2.5h， 生成 1-(4-hydroxyphenyl)dihydropyrimidine-2,4(1H,3H)-dione
  参考文献：
  名称：

  [EN] ESTROGEN RECEPTOR DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS
  [FR] AGENTS DE DÉGRADATION DU RÉCEPTEUR DES ŒSTROGÈNES, COMPOSITIONS PHARMACEUTIQUES ET APPLICATIONS THÉRAPEUTIQUES

  摘要：

  Provided herein are estrogen receptor degraders, for example, a compound of Formula (I), RT–L–RE; and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of an estrogen receptor-mediated disorder, disease, or condition.

  公开号：

  WO2023023531A1
• 作为产物：
  描述：

  甲氧苯胺 在 sodium hydroxide 、 溶剂黄146 作用下， 生成 3-(4-甲氧基苯氨基)-丙酸
  参考文献：
  名称：

  由β-苯胺基丙酸合成4-羟基和4-氯喹啉的实验。

  摘要：

  DOI：

  10.1021/ja01211a037

文献信息

• WRINKLE-IMPROVING AGENT
  申请人：Shiseido Company, Limited

  公开号：EP1941861A1

  公开（公告）日：2008-07-09

  The invention provides a novel wrinkle-improving agent that has an effect of improving wrinkles, that does not entail problems of safety or pain even when applied to the skin, and that contains a very safe substance as an active component. A discovery was made that N-benzoyl-β-alanine, other specific β-alanine derivatives, and salts thereof have a wrinkle-improving effect, whereby a wrinkle-improving agent containing as an active component one, two, or more types of compounds selected from the group composed of these specific β-alanine derivatives and the salts thereof was developed.

  该发明提供了一种新型的改善皱纹的剂，具有改善皱纹的效果，即使应用于皮肤也不会带来安全或疼痛问题，并且包含一种非常安全的物质作为活性成分。发现N-苯甲酰-β-丙氨酸、其他特定的β-丙氨酸衍生物及其盐具有改善皱纹的效果，因此开发了一种改善皱纹的剂，其活性成分包含从这些特定的β-丙氨酸衍生物及其盐组成的群体中选择的一种、两种或更多种化合物。
• Process for the preparation of 4-quinolinones
  申请人：Rhone-Poulenc Sante

  公开号：US04585867A1

  公开（公告）日：1986-04-29

  1,2,3,4-Tetrahydro-4-quinolinones of the formula ##STR1## are prepared from a 3-anilinopropionic acid of general for formula ##STR2## which is treated successively with phosgene, with a base or by heating, and then with a Lewis acid or a strong acid. In the formulae (I) and (II), R denotes a hydrogen atom, a halogen atom, an alkyl radical (1 to 4 carbon atoms) or an alkoxy radical (1 to 4 carbon atoms), and R.sub.1 denotes a hydrogen atom or any alkyl radical (1 to 4 carbon atoms). The compounds of formula I are useful as intermediates in the production of known drugs.

  公式为##STR1##的1,2,3,4-四氢-4-喹啉酮是从一般公式为##STR2##的3-苯胺丙酸制备而来的，该酸经过磷酰氯、碱或加热处理，然后再与Lewis酸或强酸处理。在公式（I）和（II）中，R代表氢原子、卤原子、烷基基团（1至4个碳原子）或烷氧基团（1至4个碳原子），R.sub.1代表氢原子或任何烷基基团（1至4个碳原子）。公式I的化合物在已知药物的生产中作为中间体是有用的。
• Synthesis of 1-aryl-2-methyl-3-ethoxycarbonyl-1,4,5,6-tetrahydro-4(1H)-pyridones and their derivatives
  作者：Vytautas Mickevicius、Jolanta Bylinskaite

  DOI：10.1016/0040-4039(96)00543-6

  日期：1996.5

  Substituted derivatives of 4(1H)tetrahydropyridones have been synthesised by reaction of N-aryl-β-alanines with ethyl acetoacetate, their hydrolysis and interaction with hydrazine, phenylhydrazine have been investigated.

  通过N-芳基-β-丙氨酸与乙酰乙酸乙酯的反应合成了4（1H）四氢吡啶酮的取代衍生物，并研究了它们的水解作用以及与肼，苯肼的相互作用。
• [EN] QUINOLONES AS T-RNA SYNTHETASE INHIBITORS AND ANTIBACTERIAL AGENTS<br/>[FR] QUINOLONES TENANT LIEU D'INHIBITEURS D'ARNT SYNTHETASE ET D'AGENTS ANTIBACTERIENS
  申请人：SMITHKLINE BEECHAM PLC

  公开号：WO2000021949A1

  公开（公告）日：2000-04-20

  Compounds of formula (I), in which: R1 is aryl or heteroaryl; R2 is hydrogen, C¿(1-6)?alkyl, arylC(1-4)alkyl, arylC(2-4)alkenyl or C(1-6)alkylcarbonyl; R?3¿ is selected from halo, cyano, hydroxy, (C¿1-6)?alkyl (optionally substituted by halo, hydroxy, amino, carboxy or (C1-6)alkoxycarbonyl), (C3-7)cycloalkyl, C(1-6)alkoxy, amino, mono- or di-(C1-6)alkylamino, acylamino, carboxy, (C1-6)alkoxycarbonyl, carboxy(C1-6)alkyloxy, (C1-6)alkylthio, (C1-6)alkylsulphinyl, (C1-6)alkylsulphonyl, sulphamoyl, mono- and di-(C1-6)alkylsulphonyl, carbamoyl, mono- and di-(C1-6)alkylcarbamoyl, and heterocyclyl; m is 0 or an integer from 1 to 3; R?4¿ and a substituent on R1 are linked to form a saturated bridge comprising one or two carbon atoms and a heteroatom selected from O and NR5; R5 is hydrogen or C¿(1-6)?alkyl; Y is a linker group having from 2 to 6 methylene groups in a straight chain and in which one or more alkylene groups may have one or more C(1-6) alkyl substituents and which substituents may be linked to form a C2 or C3 alkylene bridge; Z is NH or O; and salts thereof, preferably pharmaceutically acceptable salts; are inhibitors of Saureus methionyl tRNA synthetase and thereof of use in therapy as antibacterial agents.

  化合物的公式（I），其中：R1是芳基或杂环芳基；R2是氢，C（1-6）烷基，芳基C（1-4）烷基，芳基C（2-4）烯基或C（1-6）烷基羰基；R3是选自卤素，氰基，羟基，（C1-6）烷基（可选地被卤素，羟基，氨基，羧基或（C1-6）烷氧羰基取代），（C3-7）环烷基，C（1-6）烷氧基，氨基，单或双（C1-6）烷基氨基，酰胺基，羧基，（C1-6）烷氧羰基，羧基（C1-6）烷氧基，（C1-6）烷基硫醇，（C1-6）烷基亚磺酰基，（C1-6）烷基磺酰基，磺酰胺基，单和双（C1-6）烷基磺酰基，氨基甲酰基，单和双（C1-6）烷基氨基甲酰基和杂环基；m为0或1至3的整数；R4和R1上的取代基连接形成饱和桥，包括一个或两个碳原子和一个选自O和NR5的杂原子；R5是氢或C（1-6）烷基；Y是具有2至6个亚甲基基团的连接基，在其中一个或多个亚甲基基团中可能有一个或多个C（1-6）烷基取代基，并且这些取代基可能连接形成C2或C3烷基桥；Z是NH或O；及其盐，优选为药物可接受盐；是Saureus甲硫氨酰-tRNA合成酶的抑制剂，因此在治疗中作为抗菌剂使用。
• AMINOPYRIDINE DERIVATIVE
  申请人：Tsukamoto Tetsuya

  公开号：US20130005710A1

  公开（公告）日：2013-01-03

  The present invention provides a novel aminopyridine derivative that is excellent in pharmaceutical effects such as a neuroprotective effect, a neurogenesis or nerve regeneration promoting effect, and a cognitive function improving effect and, preferably, is low toxic and delivered at a high rate to the central nervous system. Specifically, the present invention provides a compound represented by the formula (I), wherein ring A represents a monocyclic aromatic hydrocarbon ring or the like; ring B may further have a substituent(s); ring D represents a monocyclic aromatic hydrocarbon ring or the like; L represents a bond, or a methylene group or the like; X represents —NRa- or the like, wherein Ra represents a hydrogen atom or the like; n represents 1 or 2; and R 1 to R 3 each represent a hydrogen atom or the like, wherein ring A and ring D each may be condensed with another ring to form a condensed ring which may have a substituent(s), and ring A-L- in the formula (I) may be bonded to X, provided that when ring A is pyrazole which may be substituted and ring D is benzene which may be substituted, L is a bond; or a salt thereof.

  本发明提供了一种新型的氨基吡啶衍生物，其在药理作用方面表现出色，如神经保护作用、神经发生或神经再生促进作用和认知功能改善作用，并且最好是低毒性并以高速递送到中枢神经系统。具体而言，本发明提供了一种由式(I)表示的化合物，其中环A表示单环芳香烃环或类似物；环B可以进一步具有取代基；环D表示单环芳香烃环或类似物；L表示键合或亚甲基基团或类似物；X表示-NRa-或类似物，其中Ra表示氢原子或类似物；n表示1或2；R1至R3各自表示氢原子或类似物，其中环A和环D各自可以与另一个环融合形成融合环，该融合环可以具有取代基，式(I)中的环A-L-可以与X键合，但当环A为可能被取代的吡唑环，环D为可能被取代的苯环时，L为键合；或其盐。